Related Experiment Video
Updated: Jul 11, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Inadequate treatment of congestive heart failure in dialysis patients
Josée Bouchard1, François Madore
1Department of Medicine, Université de Montréal, and Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
Abstract:
Congestive heart failure (CHF) is highly prevalent in patients on renal replacement therapy and is a leading cause of death in such patients. Several studies suggest that therapeutic agents for the treatment of CHF, particularly angiotensin converting enzyme inhibitors and beta-blockers, are underused in end-stage renal disease patients with CHF. Although limited data are available, growing evidence suggests that therapeutic agents for CHF improve survival and are safe to use, assuming close monitoring of adverse events. The reluctance of physicians in prescribing these therapeutic agents and the reasons underlying the inconsistent use of these agents in the dialysis population need to be addressed.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure VI: Adjunct Therapies
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management